PSMA PET/CT in Prostate Cancer: Staging, Restaging, and Treatment Planning

This 1.0-credit enduring activity provides oncologists, urologists, and radiologists with a practical, case-based review of PSMA PET/CT imaging in prostate cancer. Through interactive exercises and clinical vignettes, participants gain the knowledge and competence to appropriately select…

Price
Free
Accredited provider:
i3 Health
Learning platform:
IQ Apparatus
Release date
November 30, 2026
Expires
December 30, 2027
Start activity

Credits

Learning objectives

Upon completion, participants should be able to:

  1. Identify the FDA-approved clinical indications for PSMA PET/CT imaging in newly diagnosed high-risk and biochemically recurrent prostate cancer
  2. Apply evidence-based risk stratification criteria to guide appropriate imaging and treatment decisions for patients with prostate cancer
  3. Interpret PSMA PET/CT findings to inform multidisciplinary treatment planning, including radiation therapy, surgery, and systemic therapy decisions

Faculty